Search Results - "Coca‐Prieto, Inmaculada"
-
1
Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic
Published in European journal of clinical investigation (01-12-2020)“…Background The aim of this study is to confirm the diagnostic performance of the Chylomicron to very low‐density lipoproteins triglycerides (CM/VLDL‐TG) ratio,…”
Get full text
Journal Article -
2
Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
Published in Med (New York, N.Y. : Online) (14-06-2024)“…Reducing the synthesis of apoC-III reduces fasting triglycerides in individuals lacking lipoprotein lipase activity. Recently, Stroes et al. published a phase…”
Get more information
Journal Article -
3
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis
Published in BMC gastroenterology (17-06-2009)“…Severe hypertriglyceridaemia due to chylomicronemia may trigger an acute pancreatitis. However, the basic underlying mechanism is usually not well understood…”
Get full text
Journal Article -
4
Validation of the IberScore model in a primary care population
Published in Clínica e investigación en arteriosclerosis (Internet, English ed.) (01-05-2024)“…This study aimed to validate the IberScore cardiovascular risk model in a population attended in the primary care setting. A cohort of patients with no history…”
Get full text
Journal Article -
5
Doctors’ perception of red wine consumption and cardiovascular health
Published in Clínica e investigación en arteriosclerosis (Internet, English ed.) (01-11-2023)Get full text
Journal Article -
6
Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome
Published in Journal of clinical lipidology (01-03-2023)“…•FCS is a rare genetic disorder that results in LPL activity deficiency.•The LPL activity method is not standardised.•Cut-off points to consider LPL activity…”
Get full text
Journal Article -
7
Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial
Published in BMJ open (07-11-2024)“…Genetic variations impact drug response, driving the need for personalised medicine through pre-emptive pharmacogenetic testing. However, the adoption of…”
Get full text
Journal Article -
8
Childhood‐onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation
Published in Journal of internal medicine (01-09-2011)“… Coca‐Prieto I, Kroupa O, Gonzalez‐Santos P, Magne J, Olivecrona G, Ehrenborg E, Valdivielso P (Hospital Virgen de la Victoria, Malaga University, Malaga,…”
Get full text
Journal Article -
9